These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 29563526)

  • 21. High-Throughput Flow Cytometry Drug Combination Discovery with Novel Synergy Analysis Software, SynScreen.
    Perez DR; Edwards BS; Sklar LA; Chigaev A
    SLAS Discov; 2018 Aug; 23(7):751-760. PubMed ID: 29842834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessing the Effect of Mycotoxin Combinations: Which Mathematical Model Is (the Most) Appropriate?
    Kifer D; Jakšić D; Šegvić Klarić M
    Toxins (Basel); 2020 Feb; 12(3):. PubMed ID: 32121330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neighbor communities in drug combination networks characterize synergistic effect.
    Zou J; Ji P; Zhao YL; Li LL; Wei YQ; Chen YZ; Yang SY
    Mol Biosyst; 2012 Oct; 8(12):3185-96. PubMed ID: 23014807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficient measurement and factorization of high-order drug interactions in
    Cokol M; Kuru N; Bicak E; Larkins-Ford J; Aldridge BB
    Sci Adv; 2017 Oct; 3(10):e1701881. PubMed ID: 29026882
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug combination sensitivity scoring facilitates the discovery of synergistic and efficacious drug combinations in cancer.
    Malyutina A; Majumder MM; Wang W; Pessia A; Heckman CA; Tang J
    PLoS Comput Biol; 2019 May; 15(5):e1006752. PubMed ID: 31107860
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An integrated framework for identification of effective and synergistic anti-cancer drug combinations.
    Sharma A; Rani R
    J Bioinform Comput Biol; 2018 Oct; 16(5):1850017. PubMed ID: 30304987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparing Mechanistic and Preclinical Predictions of Volume of Distribution on a Large Set of Drugs.
    Chan R; De Bruyn T; Wright M; Broccatelli F
    Pharm Res; 2018 Mar; 35(4):87. PubMed ID: 29520503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PBPK and its Virtual Populations: the Impact of Physiology on Pediatric Pharmacokinetic Predictions of Tramadol.
    T'jollyn H; Vermeulen A; Van Bocxlaer J
    AAPS J; 2018 Nov; 21(1):8. PubMed ID: 30498862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Quantitative estimation of potentiating or inhibitory effects of similarly acting drugs in combination. Advantages of a dose-response curve method over the isoboles-method (author's transl)].
    Pöch G
    Arzneimittelforschung; 1981; 31(7):1135-40. PubMed ID: 7196763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessing in vitro combinations of antifungal drugs against yeasts and filamentous fungi: comparison of different drug interaction models.
    Meletiadis J; Verweij PE; TeDorsthorst DT; Meis JF; Mouton JW
    Med Mycol; 2005 Mar; 43(2):133-52. PubMed ID: 15832557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug combination studies and their synergy quantification using the Chou-Talalay method.
    Chou TC
    Cancer Res; 2010 Jan; 70(2):440-6. PubMed ID: 20068163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An overview of drug combination analysis with isobolograms.
    Tallarida RJ
    J Pharmacol Exp Ther; 2006 Oct; 319(1):1-7. PubMed ID: 16670349
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The application of drug dose equivalence in the quantitative analysis of receptor occupation and drug combinations.
    Tallarida RJ; Raffa RB
    Pharmacol Ther; 2010 Aug; 127(2):165-74. PubMed ID: 20546783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overlooked Issues on Pharmacokinetics Data Interpretation of Protein Drugs-a Case Example of Erythropoietin.
    An G; Schmidt RL; Mock DM; Veng-Pedersen P; Widness JA
    AAPS J; 2018 Nov; 21(1):6. PubMed ID: 30478521
    [No Abstract]   [Full Text] [Related]  

  • 35. TAIJI: approaching experimental replicates-level accuracy for drug synergy prediction.
    Li H; Hu S; Neamati N; Guan Y
    Bioinformatics; 2019 Jul; 35(13):2338-2339. PubMed ID: 30462169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A general pharmacodynamic interaction model identifies perpetrators and victims in drug interactions.
    Wicha SG; Chen C; Clewe O; Simonsson USH
    Nat Commun; 2017 Dec; 8(1):2129. PubMed ID: 29242552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preclinical versus clinical drug combination studies.
    Chou TC
    Leuk Lymphoma; 2008 Nov; 49(11):2059-80. PubMed ID: 19021049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Statistical analysis of combined dose effects for experiments with two agents.
    Wagenpfeil S; Treiber U; Lehmer A
    Artif Intell Med; 2006 May; 37(1):65-71. PubMed ID: 16497492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimizing combination chemotherapy by controlling drug ratios.
    Mayer LD; Janoff AS
    Mol Interv; 2007 Aug; 7(4):216-23. PubMed ID: 17827442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SynergyFinder: a web application for analyzing drug combination dose-response matrix data.
    Ianevski A; He L; Aittokallio T; Tang J
    Bioinformatics; 2017 Aug; 33(15):2413-2415. PubMed ID: 28379339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.